134 related articles for article (PubMed ID: 1852906)
1. Characteristics of dose-response relationships for late radiation effects: an analysis of skin telangiectasia and of head and neck morbidity.
Turesson I
Radiother Oncol; 1991 Mar; 20(3):149-58. PubMed ID: 1852906
[TBL] [Abstract][Full Text] [Related]
2. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships.
Turesson I
Radiother Oncol; 1989 Jul; 15(3):217-26. PubMed ID: 2772250
[TBL] [Abstract][Full Text] [Related]
3. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
Bentzen SM; Saunders MI; Dische S
Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
[TBL] [Abstract][Full Text] [Related]
4. Individual variation and dose dependency in the progression rate of skin telangiectasia.
Turesson I
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1569-74. PubMed ID: 2262383
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of skin telangiectasia for late radiation effects in different normal tissues.
Turesson I; Notter G
Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):603-9. PubMed ID: 3084405
[TBL] [Abstract][Full Text] [Related]
6. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up.
Turesson I; Thames HD
Radiother Oncol; 1989 Jun; 15(2):169-88. PubMed ID: 2762590
[TBL] [Abstract][Full Text] [Related]
7. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy.
Johansen J; Bentzen SM; Overgaard J; Overgaard M
Radiother Oncol; 1996 Aug; 40(2):101-9. PubMed ID: 8884963
[TBL] [Abstract][Full Text] [Related]
9. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy.
Bentzen SM; Overgaard M
Radiother Oncol; 1991 Mar; 20(3):159-65. PubMed ID: 1852907
[TBL] [Abstract][Full Text] [Related]
10. Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: a graded-response analysis.
Bentzen SM; Turesson I; Thames HD
Radiother Oncol; 1990 Jun; 18(2):95-106. PubMed ID: 2367694
[TBL] [Abstract][Full Text] [Related]
11. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy.
Safwat A; Bentzen SM; Turesson I; Hendry JH
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):198-204. PubMed ID: 11777639
[TBL] [Abstract][Full Text] [Related]
12. Dose-time relationships for post-irradiation cutaneous telangiectasia.
Cohen L; Ubaldi SE
Int J Radiat Oncol Biol Phys; 1977; 2(5-6):421-6. PubMed ID: 407193
[No Abstract] [Full Text] [Related]
13. Does the interval between fractions matter in the range of 4-8 h in radiotherapy? A study of acute and late human skin reactions.
Nyman J; Turesson I
Radiother Oncol; 1995 Mar; 34(3):171-8. PubMed ID: 7631023
[TBL] [Abstract][Full Text] [Related]
14. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
[TBL] [Abstract][Full Text] [Related]
15. Moist desquamation and telangiectasia in patients treated by postmastectomy irradiation.
Thames HD
Radiother Oncol; 1991 Mar; 20(3):207-8. PubMed ID: 1852913
[No Abstract] [Full Text] [Related]
16. How valid is the assumption of equal effect per fraction?
Rezvani M; Ross G; Morris GM; Bywaters A; Wilkinson JH; Hopewell JW
Radiother Oncol; 1999 Dec; 53(3):227-31. PubMed ID: 10660203
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
Bentzen SM; Overgaard M; Overgaard J
Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261
[TBL] [Abstract][Full Text] [Related]
18. The influence of fraction size in radiotherapy on the late normal tissue reaction--I: Comparison of the effects of daily and once-a-week fractionation on human skin.
Turesson I; Notter G
Int J Radiat Oncol Biol Phys; 1984 May; 10(5):593-8. PubMed ID: 6735750
[TBL] [Abstract][Full Text] [Related]
19. The influence of fraction size in radiotherapy on the late normal tissue reaction--II: Comparison of the effects of daily and twice-a-week fractionation on human skin.
Turesson I; Notter G
Int J Radiat Oncol Biol Phys; 1984 May; 10(5):599-606. PubMed ID: 6429092
[TBL] [Abstract][Full Text] [Related]
20. Association between maximal skin dose and breast brachytherapy outcome: a proposal for more rigorous dosimetric constraints.
Cuttino LW; Heffernan J; Vera R; Rosu M; Ramakrishnan VR; Arthur DW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e173-7. PubMed ID: 21310550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
